
© 2025 wallstreetONLINE
Realtime | Geld | Brief | Zeit |
---|---|---|---|
118,20 | 120,80 | 12:45 | |
118,70 | 120,60 | 12:43 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | Companies Reporting: Fevertree, Vistry, Next | ||
10.03. | Retail Trust, NEXT and Dobbies Create community hub for retired retail workers | ||
10.03. | IN BRIEF: Great Portland Estates signs retailer Next to office space | ||
07.03. | Vertex Pharmaceuticals Incorporated: Vertex Announces UK MHRA Approval of ALYFTREK (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis | - Deutivacaftor/tezacaftor/vanzacaftor approved for people with cystic fibrosis 6 years and older with at least one responsive mutation in the CFTR gene, including additional mutations not previously... ► Artikel lesen | |
03.03. | Next PLC - Total Voting Rights |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
07:54 | Goldman Sachs cuts Sodexo stock rating to neutral, slashes target | ||
Fr | Sodexo (OTCMKTS:SDXAY) Hits New 12-Month Low - Here's What Happened | ||
Fr | Deutsche Bank Research stuft Sodexo herab: Auswirkungen auf den Markt | ||
Fr | ANALYSE-FLASH: Deutsche Bank Research senkt Sodexo auf 'Hold' | FRANKFURT (dpa-AFX Broker) - Deutsche Bank Research hat Sodexo nach einer Gewinnwarnung von "Buy" auf "Hold" abgestuft und das Kursziel von 93 auf 73 Euro gesenkt. Das Cateringunternehmen habe dem... ► Artikel lesen | |
Fr | Sodexo downgraded by analysts as weak sales and contract losses raise concerns |